Literature DB >> 10681573

GD3 synthase gene expression in PC12 cells results in the continuous activation of TrkA and ERK1/2 and enhanced proliferation.

S Fukumoto1, T Mutoh, T Hasegawa, H Miyazaki, M Okada, G Goto, K Furukawa, T Urano.   

Abstract

A rat pheochromocytoma cell line (PC12) transfected with ganglioside GD3 synthase gene showed a marked change in the ganglioside profile and enhanced proliferation and no response of neurite extension to nerve growth factor (NGF) stimulation. In these transfectant cells, a continuous phosphorylation of TrkA and the activation of ERK1/2 without NGF treatment were observed. Proliferation inhibition experiments with kinase inhibitors such as herbimycin A, K-252a, and PD98059 revealed that the enhanced proliferation was actually due to the activation of the Ras/MEK/ERK pathway. A TrkA dimer was detected in the GD3 synthase transfectant cells regardless of NGF treatment by cross-linking and immunoblotting. The increased expression of GD1b and GT1b in these transfectant cells might induce the conformational change of TrkA to form a dimer and to be activated continuously. These results may indicate regulatory roles of gangliosides in cell proliferation under physiological and malignant processes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10681573     DOI: 10.1074/jbc.275.8.5832

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  A ganglioside-specific sialyltransferase localizes to axons and non-Golgi structures in neurons.

Authors:  C A Stern; M Tiemeyer
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

2.  GD3 expression in CHO-K1 cells increases growth rate, induces morphological changes, and affects cell-substrate interactions.

Authors:  Jose L Daniotti; Adolfo R Zurita; Vera M T Trindade; Hugo J F Maccioni
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

Review 3.  Sialyltransferases in cancer.

Authors:  F Dall'Olio; M Chiricolo
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

4.  Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells.

Authors:  Kazunori Hamamura; Keiko Furukawa; Takanori Hayashi; Takeshi Hattori; Junji Nakano; Hideyuki Nakashima; Tetsuya Okuda; Hideki Mizutani; Hisashi Hattori; Minoru Ueda; Takeshi Urano; Kenneth O Lloyd; Koichi Furukawa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-22       Impact factor: 11.205

Review 5.  Functional roles of glycosphingolipids in signal transduction via lipid rafts.

Authors:  K Kasahara; Y Sanai
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

6.  Low complex ganglioside expression characterizes human neuroblastoma cell lines.

Authors:  Simone Hettmer; Stephan Ladisch; Karen Kaucic
Journal:  Cancer Lett       Date:  2005-01-07       Impact factor: 8.679

Review 7.  Gangliosides with O-acetylated sialic acids in tumors of neuroectodermal origin.

Authors:  Guido Kohla; Eggert Stockfleth; Roland Schauer
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

8.  Beta-amyloid-induced synthesis of the ganglioside GD3 is a requisite for cell cycle reactivation and apoptosis in neurons.

Authors:  Agata Copani; Daniela Melchiorri; Andrea Caricasole; Francesca Martini; Patrizio Sale; Roberto Carnevale; Roberto Gradini; Maria Angela Sortino; Luisa Lenti; Ruggero De Maria; Ferdinando Nicoletti
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

9.  Gangliosides trigger inflammatory responses via TLR4 in brain glia.

Authors:  Ilo Jou; Jee Hoon Lee; Soo Young Park; Hee Jung Yoon; Eun-Hye Joe; Eun Jung Park
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

10.  The roles of glycosphingolipids in the proliferation and neural differentiation of mouse embryonic stem cells.

Authors:  Ji-Ung Jung; Kinarm Ko; Dae-Hoon Lee; Kisung Ko; Kyu-Tae Chang; Young-Kug Choo
Journal:  Exp Mol Med       Date:  2009-12-31       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.